ArticlePlastic and reconstructive surgery. Global open2017
Botulinum Toxin A as an Adjunct to Abdominal Wall Reconstruction for Incisional Hernia.
Article in Plastic and reconstructive surgery. Global open, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT04143776 (Renal- and Pulmonary Function in Relation to Abdominal Hypertension After Abdominal Reconstruction), which is not on this map. Cited by 24 papers, 3 of them syntheses that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Renal- and Pulmonary Function in Relation to Abdominal Hypertension After Abdominal Reconstruction: The REPARE-study
Who cites it
24 citing papers in PubMed, 3 syntheses or guidelines pooled it, 57 citations in OpenAlex.
- Effect of preoperative botulinum toxin injection in the treatment of giant incisional hernias: a systematic review and meta-analysis.Hernia : the journal of hernias and abdominal wall surgery · 2025Pooled it
- Systematic review and meta-analysis of the pre-operative application of botulinum toxin for ventral hernia repair.Hernia : the journal of hernias and abdominal wall surgery · 2023Pooled it
- Prehabilitation of complex ventral hernia patients with Botulinum: a systematic review of the quantifiable effects of Botulinum.Hernia : the journal of hernias and abdominal wall surgery · 2021Pooled it
- Case series: oncologic patients in remission with giant ventral hernia treated with botulinum toxin and component separation.Journal of surgical case reports · 2026Article
- Case Report: Intraoperative Fascial Traction for Increasing Intra-Abdominal Volume in Loss-of-Domain Incisional Hernias: A Report of Two Cases.Journal of abdominal wall surgery : JAWS · 2025Article
- Preoperative abdominal wall Botulinum A toxin in the outpatient pain clinic prior to complex abdominal wall repair: A letter to the editor.Interventional pain medicine · 2024Article
- Exploring New and Potential Indications for Botulinum Toxin Treatment: An Updated Literature Review.Cureus · 2024Review
- Giant Inguino-Scrotal Hernia With Loss of Domain: Surgical Report and Literature Review.Cureus · 2024Article
- The effect of preoperative botulinum toxin a injection on traction force during hernia repair: a prospective, single-blind study, intra-patient comparison using contralateral side as a control.Hernia : the journal of hernias and abdominal wall surgery · 2024Article
- Achieving fascial closure with preoperative botulinum toxin injections in abdominal wall reconstruction: outcomes from a high-volume center.Updates in surgery · 2024Article
- Article
- Article
- A computed tomography study investigating the effects of botulinum toxin injections prior to complex abdominal wall reconstruction.Hernia : the journal of hernias and abdominal wall surgery · 2023Article
- Comparison of Two Versus Three Bilateral Botulinum Toxin Injections Prior to Abdominal Wall Reconstruction.Journal of abdominal wall surgery : JAWS · 2023Article
- Article
- Abdominal Viscera Migration Performing Hemodynamic Instability after Esophagectomy: A Case Report.Gastrointestinal tumors · 2021Article
- A structured pathway for developing your complex abdominal hernia service: our York pathway.Hernia : the journal of hernias and abdominal wall surgery · 2021Article
- Closing Difficult Laparostomies With the Aid of Botulinum Toxin A: An Audit of 12 Cases.Cureus · 2021Article
- Linear versus volumetric CT analysis in predicting tension-free fascial closure in abdominal wall reconstruction.Hernia : the journal of hernias and abdominal wall surgery · 2021Article
- Preoperative botulinum toxin type A: A case report of a proposed new strategy for giant hiatal hernia management.Clinical case reports · 2020Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors at 3 institutions in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundRepair of large incisional hernias remains a surgical and costly challenge. Temporary paralysis of the lateral abdominal wall muscles with topical administration of botulinum toxin A (BTA) is a new therapeutic concept, which may obviate the need for component separation technique (CST) for repair of large incisional hernias. Current literature on the administration of BTA as adjunct to surgical repair of abdominal incisional hernias was investigated.
methodsThe electronic databases PubMed and Embase were searched for eligible studies. Two independent investigators evaluated the literature. Data were sought regarding primary fascial closure with and without CST, safety, hernia recurrence, method of application, and preoperative radiological imaging.
resultsSix cohort studies including a total of 133 patients receiving BTA were identified. No randomized or case-control studies were found. In total, 83.5% of the patients achieved primary fascial closure. Supplemental CST was necessary in 24.1% of the patients. Two patients developed hernia recurrence during follow-up. No postoperative complications or adverse events were considered related to the administration of BTA, except for impairment of postoperative coughing and sneezing. Additionally, radiological imaging showed that BTA increased the length of lateral abdominal muscles before surgery.
conclusionsPreoperative administration of BTA increases muscle length and may facilitate primary fascial closure. Optimal administration is at least 2 weeks before repair, whereas the optimal dose of BTA remains to be defined. Carefully designed randomized controlled trials are warranted to identify patients who would benefit from BTA and to eliminate the confounding effect of CST.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.